BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8741988)

  • 1. Characterization of single site ricin toxin B chain mutants.
    Frankel A; Tagge E; Chandler J; Burbage C; Hancock G; Vesely J; Willingham M
    Bioconjug Chem; 1996; 7(1):30-7. PubMed ID: 8741988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ricin toxin contains at least three galactose-binding sites located in B chain subdomains 1 alpha, 1 beta, and 2 gamma.
    Frankel AE; Burbage C; Fu T; Tagge E; Chandler J; Willingham MC
    Biochemistry; 1996 Nov; 35(47):14749-56. PubMed ID: 8942636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-lectin site ricin B chain mutants expressed in insect cells have residual galactose binding: evidence for more than two lectin sites on the ricin toxin B chain.
    Fu T; Burbage C; Tagge E; Chandler J; Willingham M; Frankel A
    Bioconjug Chem; 1996; 7(6):651-8. PubMed ID: 8950484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of ricin B chain in Spodoptera frugiperda.
    Frankel A; Roberts H; Gulick H; Afrin L; Vesely J; Willingham M
    Biochem J; 1994 Nov; 303 ( Pt 3)(Pt 3):787-94. PubMed ID: 7980448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preproricin expressed in Nicotiana tabacum cells in vitro is fully processed and biologically active.
    Tagge EP; Chandler J; Harris B; Czako M; Marton L; Willingham MC; Burbage C; Afrin L; Frankel AE
    Protein Expr Purif; 1996 Aug; 8(1):109-18. PubMed ID: 8812841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-site ricin B chain mutants retain galactose binding.
    Frankel A; Tagge E; Chandler J; Burbage C; Willingham M
    Protein Eng; 1996 Apr; 9(4):371-9. PubMed ID: 8738213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of oligohistidine-tagged ricin B chain in Spodoptera frugiperda.
    Afrin LB; Gulick H; Vesely J; Willingham M; Frankel AE
    Bioconjug Chem; 1994; 5(6):539-46. PubMed ID: 7533004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renaturated ricin toxin B chain made in Escherichia coli is soluble, stable, and biologically active.
    Tonevitsky A; Toptygin A; Agapov I; Pfueller U; Frankel A
    Biochem Mol Biol Int; 1994 Apr; 32(6):1139-46. PubMed ID: 8061631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of functional ricin B chain using the baculovirus system.
    Ferrini JB; Martin M; Taupiac MP; Beaumelle B
    Eur J Biochem; 1995 Nov; 233(3):772-7. PubMed ID: 8521841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a ricin fusion toxin targeted to the interleukin-2 receptor.
    Frankel AE; Burbage C; Fu T; Tagge E; Chandler J; Willingham M
    Protein Eng; 1996 Oct; 9(10):913-9. PubMed ID: 8931131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ricin toxin contains three lectin sites which contribute to its in vivo toxicity.
    Fu T; Burbage C; Tagge EP; Brothers T; Willingham MC; Frankel AE
    Int J Immunopharmacol; 1996 Dec; 18(12):685-92. PubMed ID: 9172011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of active, processed ricin in transgenic tobacco.
    Sehnke PC; Pedrosa L; Paul AL; Frankel AE; Ferl RJ
    J Biol Chem; 1994 Sep; 269(36):22473-6. PubMed ID: 8077191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of green fluorescent protein-ricin and monitoring of its intracellular trafficking.
    Tagge E; Harris B; Burbage C; Hall P; Vesely J; Willingham M; Frankel A
    Bioconjug Chem; 1997; 8(5):743-50. PubMed ID: 9327140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL2-ricin fusion toxin is selectively cytotoxic in vitro to IL2 receptor-bearing tumor cells.
    Frankel A; Tagge E; Chandler J; Burbage C; Hancock G; Vesely J; Willingham M
    Bioconjug Chem; 1995; 6(6):666-72. PubMed ID: 8608178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL2 fused to lectin-deficient ricin is toxic to human leukemia cells expressing the IL2 receptor.
    Frankel AE; Fu T; Burbage C; Chandler J; Willingham MC; Tagge EP
    Leukemia; 1997 Jan; 11(1):22-30. PubMed ID: 9001414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-application of ricin A chain and a recombinant adenovirus expressing ricin B chain as a novel approach for cancer therapy.
    Wang HB; Xia F; Ge J; Yin J; Tan LS; Zhang PD; Zhong J
    Acta Pharmacol Sin; 2007 May; 28(5):657-62. PubMed ID: 17439722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Processing of preproricin in transgenic tobacco.
    Sehnke PC; Ferl RJ
    Protein Expr Purif; 1999 Mar; 15(2):188-95. PubMed ID: 10049674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Production of biologically active recombinant ricin B-chain].
    Tonevitskiĭ AG; Toptygin AIu; Agapov II; Rakhmanova VA; Shamshiev AT; Alekseev IuO; Pfueller U; Frankel A
    Mol Biol (Mosk); 1995; 29(2):398-406. PubMed ID: 7783743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lectin-deficient ricin toxin intoxicates cells bearing the D-mannose receptor.
    Frankel AE; Fu T; Burbage C; Tagge E; Harris B; Vesely J; Willingham MC
    Carbohydr Res; 1997 May; 300(3):251-8. PubMed ID: 9202409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ricin fusion toxin targeted to the human granulocyte-macrophage colony stimulating factor receptor is selectively toxic to acute myeloid leukemia cells.
    Burbage C; Tagge EP; Harris B; Hall P; Fu T; Willingham MC; Frankel AE
    Leuk Res; 1997 Jul; 21(7):681-90. PubMed ID: 9301690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.